Smits A, van Grieken D, Hartman M, Lendahl U, Funa K, Nistér M
Department of Neurology, University Hospital, Uppsala, Sweden.
Lab Invest. 1996 Jan;74(1):188-98.
Medulloblastomas and related childhood primitive neuroectodermal tumors (PNET) are currently thought to originate from a multipotent stem cell that can give rise to a variety of different tumor types, representing different lines of differentiation and stages of maturation of the original stem cell. The proliferation and differentiation of different cell types in the central nervous system are influenced by growth factors, such as platelet-derived growth factor (PDGF). In this study, we investigated the expression of the two types of PDGF receptors, alpha and beta, on 14 cases of PNET by immunohistochemistry and in situ hybridization. To characterize the tumor cells according to their differentiation and maturation, we performed immunohistochemistry with Ab against several members of the intermediate filament family, such as neurofilament, glial fibrillary acidic protein, vimentin, and the embryonal marker nestin. For the cerebral PNET, we found that the phenotype of multidirectional differentiation (with coexpression of neurofilament, glial fibrillary acidic protein, vimentin, and in some cases nestin) was associated with the expression of both PDGF alpha and beta receptors on the tumor cells. Medulloblastomas (i.e., cerebellar PNET), however, often showed the phenotype of partially committed neuron-like precursor cells, and this was associated with the predominant expression of PDGF alpha receptors on the tumor cells. Our findings show that the PDGF alpha receptor, previously known to play a role in the normal development of cells of the glial lineage, either exclusively or in combination with the PDGF beta receptor, is expressed on tumor cells of neuronal derivation. This "aberrant" expression of PDGF alpha receptors on PNET may reflect a feature of the malignant phenotype of these tumors. Further studies are needed to study the biologic effects of PDGF-A and its receptor in PNET.
髓母细胞瘤及相关儿童原始神经外胚层肿瘤(PNET)目前被认为起源于一种多能干细胞,这种干细胞可产生多种不同的肿瘤类型,代表着原始干细胞不同的分化谱系和成熟阶段。中枢神经系统中不同细胞类型的增殖和分化受生长因子影响,如血小板衍生生长因子(PDGF)。在本研究中,我们通过免疫组织化学和原位杂交技术,研究了14例PNET中两种类型的PDGF受体(α和β)的表达情况。为根据肿瘤细胞的分化和成熟情况对其进行特征描述,我们使用针对中间丝蛋白家族多个成员的抗体进行免疫组织化学检测,如神经丝蛋白、胶质纤维酸性蛋白、波形蛋白以及胚胎标志物巢蛋白。对于脑PNET,我们发现多向分化表型(神经丝蛋白、胶质纤维酸性蛋白、波形蛋白共表达,在某些情况下还有巢蛋白表达)与肿瘤细胞上PDGFα和β受体的表达相关。然而,髓母细胞瘤(即小脑PNET)通常表现出部分定向神经元样前体细胞的表型,这与肿瘤细胞上PDGFα受体的优势表达相关。我们的研究结果表明,先前已知在胶质谱系细胞正常发育中发挥作用的PDGFα受体,单独或与PDGFβ受体联合,在神经源性肿瘤细胞上表达。PNET上PDGFα受体的这种“异常”表达可能反映了这些肿瘤恶性表型的一个特征。需要进一步研究PDGF - A及其受体在PNET中的生物学效应。